News | September 20, 2011

National Survey Reveals That A False Positive Experience Does Not Deter Women From Having Additional Tests To Find Cancer Early

September 20, 2011 – A national survey found that women overwhelmingly want the option for additional screening tests to find cancer early, even when testing resulted in a false positive – a suspicious area found by biopsy to be non-cancerous. Nine out of 10 women who required a biopsy to determine a false positive indicated that they would still opt for the additional screening the following year.

While 55 percent of women surveyed experience anxiety while waiting for the results of their yearly mammogram, 80 percent of those women do not let anxiety deter them from their next scheduled mammogram. Results demonstrate that women have regular screening mammograms for the benefit of the early detection of cancer and would choose additional screening measures to give them the best chance of early detection. This is particularly notable for women for whom a mammogram is compromised due to dense breast tissue; as density increases, the sensitivity of mammography decreases, missing cancer at least 40 percent of the time.

In fact, 93 percent of women, if informed of their dense breast tissue, would elect for an additional screening test. Clinical studies have shown that women with dense breasts may benefit from adjuvant screening modalities such as molecular breast imaging (MBI), magnetic resonance imaging (MRI) and ultrasound, which are more sensitive than mammography and thus may yield more false positives. It has long been maintained that “anxiety” over a false positive is a stressful and possibly emotionally debilitating experience for women. This concern is one of the most frequently cited objections to legislative efforts seeking to standardize the communication of breast density to women.

“This survey clearly shows that women want all the relevant information about their own breast health,” said Wendie Berg, M.D., radiologist and principal investigator and chair of the ACRIN 6666 Study. “In women with dense breasts, mammography is more likely not to show the cancer if present and women with dense breasts are also at increased risk of developing breast cancer. Women should have the information needed to advocate for themselves in this process.”

The national survey of 1,000 women aged 40 to 64 was conducted online in August 2011 by Research Now. Commissioned by Are You Dense Inc., the results indicate a clear preference by women for a false positive over a potentially life threatening missed positive.

“While medical authorities must weigh scientific evidence and recommend to the lay public whether, how often and with what tests women should be screened for breast cancer, there are times when these authorities must take into account women's preferences. These include patient anxiety and the issue of false positive examinations. The issue of false positives is not only patient anxiety but also the cost to society of these examinations,” said Thomas Kolb, M.D., a radiological expert and author of the first published contemporary study detailing the use of screening breast ultrasound to detect cancers. “When evaluating costs one must ask whether a recommendation not to screen is influenced by insurance companies’ profits or government healthcare costs. If so, women may be angered to find that economics, in the guise of science, had any influence in healthcare recommendations. There is a time and place where women should take part in decisions affecting their health and this is one of them.” 

“Since my advanced stage cancer diagnosis in 2004, after dutifully having my yearly mammogram, I’ve met women with the same tragic story – a missed positive – that resulted in advanced cancer, aggressive treatment and the likelihood of dying prematurely from breast cancer. These women would exchange their missed positive any day for a false positive,” said Nancy Cappello, M.D., founder of Are You Dense Inc., who was instrumental in the first law in the nation to standardize the communication of breast density in women through the mammography report.

According to JoAnn Pushkin, director of government relations for Are You Dense Advocacy Inc., the communication of breast density to women, through their mammography report, is critical in finding cancers early. “If I had been told that, due to density, the ability of my mammogram to find cancer was little better than a coin toss, of course I would have begun a discussion with my doctor about the possibility of additional screening. Without density notification, the 40 percent of women with dense breasts are effectively being denied equal access to early detection.”  

For more information: www.AreYouDense.org, www.AreYouDenseAdvocacy.org

 

Related Content

Breast Density Advocate Nancy M. Cappello Passes Away

Nancy Cappello. Image courtesy of AreYouDense.org.

News | Breast Density | November 15, 2018 | Jeff Zagoudis, Associate Editor
Imaging Technology News extends its condolences to the family, friends and colleagues of Nancy M. Cappello, Ph.D., who...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...
Feature | Breast Imaging | November 07, 2018 | By Jeff Zagoudis
Breast imaging technology has experienced major growth over the last decade or so, and a new report suggests the mark
Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing  information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Feature | Breast Imaging | November 05, 2018 | By Jeff Zagoudis
The incidence of breast cancer is rising globally, with an estimated 1 in 8 women diagnosed in their lifetime and 40,...
Deaconess Health System Chooses Sectra as Enterprise Imaging Vendor
News | Enterprise Imaging | November 02, 2018
International medical imaging information technology (IT) and cybersecurity company Sectra will install its enterprise...
Volpara Enterprise Cloud Reaches 1 Million Mammograms Stored
News | Mammography | October 31, 2018
Volpara Solutions announced that the data stored in the Volpara Enterprise cloud now exceeds 1 million mammographic...
Philips Debuts Integrated Breast Ultrasound Solution
News | Ultrasound Women's Health | October 26, 2018
Philips announced what it calls its ultimate ultrasound solution for breast assessment, available with the Philips Epiq...